Im sorry I have been reading announcements again and the comments are that efficacy data timing is largely unchanged. Where are you getting info for these major delays. I am genuinely interested as a holder and if I’m wrong I’m wrong.
We also have the GE announcements coming through soon (I’m not aware of many other companies on the asx at this MC value with this type of relationship with a major).
Ann: AD-214 pathway to IPF efficacy studies, page-60
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
